Related references
Note: Only part of the references are listed.Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients
Khaled Elsayad et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2020)
De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma
Michael Oertel et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2020)
Volume de-escalation in radiation therapy: state of the art and new perspectives
Bruno Meduri et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial
Paul J. Broeckelmann et al.
JAMA ONCOLOGY (2020)
Comparative treatment planning study for mediastinal Hodgkin's lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy
Anneli Edvardsson et al.
ACTA ONCOLOGICA (2019)
Risk of Pneumonitis and Pneumonia Associated With Immune Checkpoint Inhibitors for Solid Tumors: A Systematic Review and Meta-Analysis
Qiang Su et al.
FRONTIERS IN IMMUNOLOGY (2019)
Treatment outcomes using involved field and involved site radiotherapy for NHL and HL: Retrospective analysis from a large UK Radiotherapy centre
D.M. Jayalathike et al.
HEMATOLOGICAL ONCOLOGY (2017)
Radiation Pneumonitis in Pediatric Hodgkin Lymphoma Patients receiving Radiotherapy to the Chest
G. Lewis et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials
Boris Boell et al.
BLOOD (2016)
Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy
S. Horn et al.
CANCER RADIOTHERAPIE (2016)
Hodgkin lymphoma: Late effects of treatment and guidelines for surveillance
Andrea K. Ng et al.
SEMINARS IN HEMATOLOGY (2016)
Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment
Flora E. van Leeuwen et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
The evolving role of response-adapted PET imaging in Hodgkin lymphoma
Michael Coyle et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2016)
Minimizing Late Effects for Patients With Mediastinal Hodgkin Lymphoma: Deep Inspiration Breath-Hold, IMRT, or Both?
Marianne C. Aznar et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential
Allison Toltz et al.
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS (2015)
Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury
Laura Cella et al.
ACTA ONCOLOGICA (2014)
Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)
Lena Specht et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Response to Comment on 'Bridging the gap between IMRT and VMAT: Dense angularly sampled and sparse intensity modulated radiation therapy' [Med. Phys. 38, 4912-4919 (2011)]
Ruijiang Li et al.
MEDICAL PHYSICS (2012)
Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations
Christian Fiandra et al.
RADIATION ONCOLOGY (2012)
Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group
Peter Borchmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy
Uwe Schneider et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2011)
Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review
Christine Herbst et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
RADIATION DOSE-VOLUME EFFECTS IN THE LUNG
Lawrence B. Marks et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial
Hans Theodor Eich et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
Andreas Engert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Breast Cancer Risk in Female Survivors of Hodgkin's Lymphoma: Lower Risk After Smaller Radiation Volumes
Marie L. De Bruin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Involved-node radiotherapy in early-stage Hodgkin's lymphoma
Hans Theodor Eich et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2008)
Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma
WG Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma:: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group
A Engert et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The involved field is back: issues in delineating the radiation field in Hodgkin's disease
J Yahalom et al.
ANNALS OF ONCOLOGY (2002)
Share Paper
